feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Antidepressants in Pregnancy: Risks of Stopping Revealed

Antidepressants in Pregnancy: Risks of Stopping Revealed

12 Feb

•

Summary

  • Stopping antidepressants nearly doubles mental health emergency risk for pregnant women.
  • Most women stopped medication, leading to over 500 more emergency visits.
  • Untreated depression poses significant risks to mother and baby.
Antidepressants in Pregnancy: Risks of Stopping Revealed

New research presented at a conference suggests that pregnant women who discontinue their antidepressants face nearly double the risk of a mental health emergency. The study, using insurance and pharmacy data from over 1,400 women in Pennsylvania, revealed that most pregnant individuals stopped their medication.

These women experienced over 500 more emergency department visits for behavioral health issues compared to those who continued treatment. Experts emphasize that while medication risks in pregnancy are often discussed, the dangers of stopping necessary treatment are equally significant.

Untreated depression during pregnancy can lead to severe consequences for both mothers and newborns, including preterm birth and increased risk of neonatal intensive care admission. For mothers, it can elevate the risk of pre-eclampsia and, in severe cases, contribute to maternal suicide.

trending

Salesforce lays off 1000

trending

India US trade tariffs slashed

trending

Margot Robbie's Wuthering Heights panned

trending

CBSE board exams: key details

trending

Jana Nayagan movie court case

trending

Dhakshineswar Suresh Davis Cup hero

trending

Deepika Padukone wears Gaurav Gupta

trending

NZ vs UAE match prediction

trending

iPhone 17 Croma Valentine's sale

While concerns exist regarding S.S.R.I. use and potential risks to the baby, such as persistent pulmonary hypertension or neonatal adaptation issues, robust data indicates that the benefits of treating depression often outweigh these risks. Some studies have suggested links to autism or miscarriage, but further research controlling for maternal mental illness has largely debunked these associations.

Alternative treatments like talk therapy, adequate sleep, nutrition, and exercise can also aid in managing mood disorders during pregnancy. However, experts advise that if a patient is stable on medication, it's often best not to interfere.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Pregnant women who stop taking antidepressants are nearly twice as likely to experience a mental health emergency and have significantly more emergency department visits for behavioral health reasons.
Untreated depression in pregnancy can lead to preterm birth, low birth weight, increased neonatal intensive care admission, and a higher risk of pre-eclampsia for the mother, alongside potential risks to maternal well-being and even suicide.
Robust observational data suggests that antidepressants, including S.S.R.I.s, are generally safe during pregnancy, and the risks associated with untreated depression are significant, though specific risks like paroxetine's link to cardiac malformations are considered.

Read more news on

Healthside-arrowPennsylvaniaside-arrow

You may also like

Stay Indoors: Unhealthy Air Grips Four States

9 Feb • 13 reads

article image

Millions More Affected by Conduent Data Breach

5 Feb • 41 reads

article image

Forever Chemicals Poisoning Private Wells Nationwide

3 Feb • 66 reads

article image

Philly Region Buried Under Record Snowfall!

26 Jan • 127 reads

article image

West's Snow Drought: Ski Season Off to Slow Start

2 Dec, 2025 • 412 reads

article image